Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage
Status:
NOT_YET_RECRUITING
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, randomized, quadruple-blind, placebo-controlled study. This study aims to estimate the safety and efficacy of intravenous tranexamic acid (TXA) combined with intensive blood pressure lowering in ultra-early spontaneous intracerebral hemorrhage (ICH).
Phase:
PHASE4
Details
Lead Sponsor:
Xuanwu Hospital, Beijing
Collaborators:
Beijing Aerospace Center Hospital Beijing Municipal Health Commission Capital Medical University Huizhou Third People's Hospital, Guangzhou Medical University Hunan Provincial People's Hospital Jiaozuo Tumor Hospital Linyi People's Hospital Nanyang Nanshi Hospital, Henan University Peking University Care Luzhong Hospital Suzhou First People's Hospital The First Affiliated Hospital of Hebei North University The First People's Hospital of Qujing, Yunnan Province The People's Hospital of Liaoning Province Wuzhou Red Cross Hospital Xing'anmeng People's Hospital Yantai Penglai Traditional Chinese Medicine Hospital